A story Thursday and accompanying graphics about Philadelphia crime rates should have noted that the 2010 statistics provided by the Police Department are preliminary and subject to change pending further investigation. Final numbers for 2010 will be established in the early part of 2011.

A "Business News in Brief" item Thursday erred in stating the current approved use for the drug Remicade. The drug, made by Centocor Ortho Biotech Inc. of Horsham, is approved by regulators for adults with moderately to severely active ulcerative colitis. The company is applying to expand the approval to children.

A story on the film No Footing gave an incorrect date for its screening at the Mainstage Center for the Arts in Camden. It will be screened at 8 p.m. Jan. 29.

The Inquirer wants its news report to be fair and correct in every respect, and regrets when it is not. If you have a question or comment about news coverage, contact assistant managing editor David Sullivan (215-854-2357) at The Inquirer, Box 8263, Philadelphia 19101, or e-mail dsullivan@phillynews.com.